{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:22:03Z","timestamp":1790698923386,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["CA100735"],"award-info":[{"award-number":["CA100735"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218771","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:15:28Z","timestamp":1785424528000},"page":"218771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Therapy-associated lineage plasticity in DIPG following combined CDK4\/6 inhibitor, temozolomide, and radiation"],"prefix":"10.1016","volume":"659","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7473-3042","authenticated-orcid":false,"given":"Zi-Lu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongchao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros M.","family":"Suarez Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9064-5846","authenticated-orcid":false,"given":"Aalaa","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ciolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5068-7128","authenticated-orcid":false,"given":"Wenan","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-2585","authenticated-orcid":false,"given":"Nitin R.","family":"Wadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Lenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-8644","authenticated-orcid":false,"given":"Michael","family":"DeCuypere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandi","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Hoesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2913-5721","authenticated-orcid":false,"given":"Ching Man","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Wray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew John","family":"Schipma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Yee","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz-Kwong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Brat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6719-3789","authenticated-orcid":false,"given":"Xiao-Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kalapurakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218771_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216876","article-title":"Diffuse intrinsic pontine glioma (DIPG): a review of current and emerging treatment strategies","volume":"590","author":"Weisbrod","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218771_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5694\/mja2.52295","article-title":"Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: australian and New Zealand children's haematology\/oncology group position statement","volume":"220","author":"Valvi","year":"2024","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.canlet.2026.218771_bib3","article-title":"Immune microenvironment and immunotherapies for diffuse intrinsic pontine glioma","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218771_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3171\/ped.2006.104.2.7","article-title":"Brainstem stereotactic biopsy sampling in children","volume":"104","author":"Pincus","year":"2006","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.canlet.2026.218771_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16091716","article-title":"Direct implantation of patient brain tumor cells into matching locations in mouse brains for patient-derived orthotopic xenograft model development","volume":"16","author":"Qi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218771_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2020.08.035","article-title":"Impact of SCID mouse gender on tumorigenicity, xenograft growth and drug-response in a large panel of orthotopic PDX models of pediatric brain tumors","volume":"493","author":"Qi","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218771_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11060-017-2372-5","article-title":"The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease","volume":"132","author":"Baugh","year":"2017","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218771_bib8","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1634\/stemcells.2007-1009","article-title":"Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma","volume":"26","author":"Shu","year":"2008","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2026.218771_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218771_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12964-021-00777-0","article-title":"Opportunities and challenges of glioma organoids","volume":"19","author":"Xu","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218771_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/2159-8290.CD-15-0894","article-title":"Targeting CDK4 and CDK6: from discovery to therapy","volume":"6","author":"Sherr","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218771_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ccell.2025.02.006","article-title":"CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety","volume":"43","author":"Palmer","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218771_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10637-014-0120-7","article-title":"Preclinical characterization of the CDK4\/6 inhibitor LY2835219: in-vivo cell cycle-dependent\/independent anti-tumor activities alone\/in combination with gemcitabine","volume":"32","author":"Gelbert","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2026.218771_bib14","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1124\/dmd.114.062745","article-title":"Brain exposure of two selective dual CDK4 and CDK6 inhibitors and the antitumor activity of CDK4 and CDK6 inhibition in combination with temozolomide in an intracranial glioblastoma xenograft","volume":"43","author":"Raub","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.canlet.2026.218771_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104686","article-title":"A unique CDK4\/6 inhibitor: current and future therapeutic strategies of abemaciclib","volume":"156","author":"Chong","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218771_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105954","article-title":"ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites","volume":"178","author":"Martinez-Chavez","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218771_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291068","article-title":"Clinical protocol: feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis","volume":"18","author":"Nduom","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218771_bib18","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1200\/JCO.23.00493","article-title":"Inaugural results of the individualized screening trial of innovative glioblastoma therapy: a phase II platform trial for newly diagnosed glioblastoma using bayesian adaptive randomization","volume":"41","author":"Rahman","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218771_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drup.2019.06.001","article-title":"Preclinical therapeutic targets in diffuse midline glioma","volume":"44","author":"Meel","year":"2019","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218771_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13046-020-01693-w","article-title":"CDK4\/6 inhibitors: a novel strategy for tumor radiosensitization","volume":"39","author":"Yang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218771_bib21","first-page":"1519","article-title":"Inhibition of DNA damage repair by the CDK4\/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth","volume":"18","author":"Hashizume","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218771_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-023-04323-5","article-title":"A novel CDK4\/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma","volume":"163","author":"Zuo","year":"2023","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218771_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218771_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101988","article-title":"Fractionated radiation therapy alters energy metabolism and induces cellular quiescence exit in patient-derived orthotopic xenograft models of high-grade glioma","volume":"45","author":"Huang","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218771_bib25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00401-020-02226-7","article-title":"Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology","volume":"140","author":"Golebiewska","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.canlet.2026.218771_bib26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3389\/fonc.2019.00875","article-title":"Development of patient-derived preclinical platform for metastatic pancreatic cancer: PDOX and a subsequent organoid model system using percutaneous biopsy samples","volume":"9","author":"Choi","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218771_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s43018-024-00893-z","article-title":"Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer","volume":"6","author":"Asciolla","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218771_bib28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41588-022-01236-3","article-title":"The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location","volume":"54","author":"Liu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218771_bib29","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41588-022-01231-8","article-title":"Defining the cell of origin for diffuse midline gliomas","volume":"54","author":"Li","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218771_bib30","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41588-022-01205-w","article-title":"K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas","volume":"54","author":"Jessa","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218771_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-025-01952-x","article-title":"Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor mediators of tumour-to-TME crosstalk","volume":"13","author":"Kordowski","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.canlet.2026.218771_bib32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s43018-025-01084-0","article-title":"De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function","volume":"7","author":"Bessler","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218771_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","article-title":"Single-cell transcriptional diversity is a hallmark of developmental potential","volume":"367","author":"Gulati","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218771_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218771_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218771_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218771_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s11658-022-00374-0","article-title":"Pou3f1 mediates the effect of Nfatc3 on ulcerative colitis-associated colorectal cancer by regulating inflammation","volume":"27","author":"Lin","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.canlet.2026.218771_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.phrs.2018.10.015","article-title":"Epigenetic targeting DNMT1 of pancreatic ductal adenocarcinoma using interstitial control release biodegrading polymer reduced tumor growth through hedgehog pathway inhibition","volume":"139","author":"Huang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218771_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2013.11.005","article-title":"Non-canonical hedgehog signaling contributes to chemotaxis in cholangiocarcinoma","volume":"60","author":"Razumilava","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218771_bib40","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41467-025-56674-4","article-title":"Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle","volume":"16","author":"Kumarasamy","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218771_bib41","article-title":"Acetaminophen-induced reduction of NIMA-related kinase 7 expression exacerbates acute liver injury","volume":"4","author":"Sun","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.canlet.2026.218771_bib42","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1182\/bloodadvances.2021005828","article-title":"HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2\/M inhibition","volume":"6","author":"Moison","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218771_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41531-022-00346-3","article-title":"Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions","volume":"8","author":"Cukier","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.canlet.2026.218771_bib44","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029280","article-title":"Beyond cell-cell adhesion: sensational cadherins for hearing and balance","volume":"10","author":"Jaiganesh","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2026.218771_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13046-021-02108-0","article-title":"Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC","volume":"40","author":"Huang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218771_bib46","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1152\/physrev.00011.2013","article-title":"Physiological roles of aquaporin-4 in brain","volume":"93","author":"Nagelhus","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2026.218771_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2012.06.045","article-title":"Connexin-based intercellular communication and astrocyte heterogeneity","volume":"1487","author":"Theis","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.canlet.2026.218771_bib48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1523\/JNEUROSCI.4178-07.2008","article-title":"A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function","volume":"28","author":"Cahoy","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.canlet.2026.218771_bib49","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.canlet.2026.218771_bib50","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218771_bib51","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41598-021-86041-4","article-title":"Molecular characterisation of rare loss-of-function NPAS3 and NPAS4 variants identified in individuals with neurodevelopmental disorders","volume":"11","author":"Rossi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218771_bib52","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s12276-024-01174-6","article-title":"NOTCH localizes to mitochondria through the TBC1D15-FIS1 interaction and is stabilized via blockade of E3 ligase and CDK8 recruitment to reprogram tumor-initiating cells","volume":"56","author":"Choi","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2026.218771_bib53","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-021-23241-6","article-title":"INPP4B promotes PI3Kalpha-dependent late endosome formation and Wnt\/beta-catenin signaling in breast cancer","volume":"12","author":"Rodgers","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218771_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cub.2009.12.030","article-title":"A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation","volume":"20","author":"Pavlowsky","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2026.218771_bib55","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1158\/0008-5472.CAN-18-0545","article-title":"Nedd4-Binding protein 1 and TNFAIP3-Interacting protein 1 control MHC-1 display in neuroblastoma","volume":"78","author":"Spel","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218771_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","article-title":"The ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs) family","volume":"16","author":"Kelwick","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2026.218771_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106676","article-title":"Discovery of a highly potent NPAS3 heterodimer inhibitor by covalently modifying ARNT","volume":"139","author":"Li","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.canlet.2026.218771_bib58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218771_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2011.06.007","article-title":"Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology","volume":"38","author":"Jansen","year":"2012","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218771_bib60","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41467-019-08905-8","article-title":"G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218771_bib61","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218771_bib63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrc2964","article-title":"Shared and separate functions of polo-like kinases and aurora kinases in cancer","volume":"10","author":"Lens","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218771_bib64","article-title":"Phase II Study of defactinib (VS6063) in patients with tumors with NF2 loss: results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol U","volume":"8","author":"Zauderer","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218771_bib65","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/sj.bjc.6603171","article-title":"Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours","volume":"94","author":"Cianfrocca","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218771_bib66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000512218","article-title":"Epithelial-mesenchymal transition (EMT) as a therapeutic target","volume":"211","author":"Jonckheere","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.canlet.2026.218771_bib67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-020-00430-1","article-title":"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218771_bib68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00381-024-06730-z","article-title":"Pediatric diffuse intrinsic pontine gliomas- a prospective observational study from a tertiary care neurosurgical center","volume":"41","author":"Chaturvedi","year":"2024","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.canlet.2026.218771_bib69","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma","volume":"386","author":"Gallego Perez-Larraya","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218771_bib70","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","article-title":"Brain Tumor microenvironment and host State: implications for immunotherapy","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:35:55Z","timestamp":1789108555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":69,"alternative-id":["S0304383526005355"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218771","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy-associated lineage plasticity in DIPG following combined CDK4\/6 inhibitor, temozolomide, and radiation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218771"}}